egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

ALISO VIEJO, Calif.–(BUSINESS WIRE)– #digitalhealth–egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 ACC Conference
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks